News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Clinical Lung Cancer – The Effectiveness of Osimertinib in Advanced NSCLC Harboring Various EGFR Exon 19 Mutation Variants
Photo: Depositphotos
May 19, 2025, 11:28

Clinical Lung Cancer – The Effectiveness of Osimertinib in Advanced NSCLC Harboring Various EGFR Exon 19 Mutation Variants

Clinical Lung Cancer posted on X:

“A new retrospective study suggests that EGFR exon 19 non-LRE deletions may be linked to poorer outcomes with osimertinib, and rare exon 19 mutations (e.g., L747P, P753L) exhibit variable responses.”

Title: Brief Report: The Effectiveness of Osimertinib in Advanced Nonsmall Cell Lung Cancer Harboring Various EGFR Exon 19 Mutation Variants

Authors: Lih-Chyun Chang, Hsiang-Wei Hu, Min-Shu Hsieh, Shang-Gin Wu, Jin-Yuan Shih

Read The Full Article.

Clinical Lung Cancer - The Effectiveness of Osimertinib in Advanced NSCLC Harboring Various EGFR Exon 19 Mutation Variants

More posts featuring NSCLC.

cancer Clinical Lung Cancer Hsiang-Wei Hu Jin-Yuan Shih Lih-Chyun Chang Min-Shu Hsieh NSCLC OncoDaily Oncology Shang-Gin Wu
Special Coverage
Science
May 19, 2025, 11:28
Clinical Lung Cancer - The Effectiveness of Osimertinib in Advanced NSCLC Harboring Various EGFR Exon 19 Mutation Variants
Blog
May 19, 2025, 11:24
Ramy Sedhom: Privilaged to be recognized in AVB Cancer Care’s 40 Under 40 for Holistic Oncology Leadership
Blog
May 19, 2025, 11:20
IMG Oncologists - Save the date ASCO IMG Community of Practice Meeting at ASCO25
Blog
May 19, 2025, 11:16
Sachin Jain: SCAN’s Leadership in PACE Model Expansion via MyPlace Health
Blog
May 19, 2025, 11:14
Naveen Pemmaraju and Gaby Hobbs Discuss Advancing Disease Modification in MPNs
Blog
May 19, 2025, 11:07
Master the Art of impactful presentations with Medical Talk Mastering Course - ESOncology
Blog
May 19, 2025, 10:58
Bishal Gyawali: President Biden’s Diagnosis of Metastatic Prostate Cancer
Blog
May 19, 2025, 10:50
Giannis Mountzios: DeLLphi-304 Trial on Tarlatamab vs SoC Chemotherapy in Patients with Pre-Treated SCLC at ASCO25
Blog
May 19, 2025, 10:41
Mohamed Janabi Nominated as Next WHO Africa Regional Director - World Health Organization African Region
Blog
May 19, 2025, 10:26
Hadi Mohamad Abu Rasheed: A Shared Mission for Hematology Care in the GCC
Blog
May 19, 2025, 10:14
Karina Herrera Schoene: The CAR-T Cell Immersion at the University of Miami
Blog
May 19, 2025, 10:12
Giannis Mountzios: Join Upcoming Discussion on DLL3 T-Cell Engagers in SCLC